Volunteers with Down’s syndrome could help find Alzheimer’s drugs
The European Union’s drugs regulator, for example, refused last summer to approve the first of them to come across its desk, though it has partially reversed that decision. And in England, despite regulatory approval, the National Health Service does not yet offer them. Many researchers suspect they might work better if given earlier, perhaps even…